FDA-issued sodium targets yield no apparent impact

MedicalXpress | июл 25, 2026

In 2021, the U.S. Food and Drug Administration (FDA) issued Phase I voluntary sodium reduction targets to encourage manufacturers to lower the amount of sodium in packaged food products by 2024. The targets appear to have had minimal impact, according to a study comparing the sodium content of new products introduced before and after the guidance was issued.